# Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment

> **NCT06587945** · PHASE4 · RECRUITING · sponsor: **Center for Eye Research Australia** · enrollment: 144 (estimated)

## Conditions studied

- Retinal Detachment

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside
- **OTHER:** Placebo
- **PROCEDURE:** Vitrectomy and Gas tamponade

## Key facts

- **NCT ID:** NCT06587945
- **Lead sponsor:** Center for Eye Research Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-19
- **Primary completion:** 2027-10-30
- **Final completion:** 2028-03-30
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06587945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06587945, "Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06587945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*